Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm in HDL Therapy
Tags: APOLIPOPROTEINS; HIGH density lipoproteins; ATHEROSCLEROSIS; ANTIOXIDANTS; ANTI-inflammatory agents; CELL adhesion molecules; MICE as laboratory animals
Related Articles
- The Anti Inflammatory Effects of High Density Lipoproteins. Murphy, A. J.; Chin-Dusting, J. P. F.; Sviridov, D.; Woollard, K. J. // Current Medicinal Chemistry;Feb2009, Vol. 16 Issue 6, p667
It is well recognised that increased levels of high density lipoprotein (HDL) protect against atherosclerosis and correlate with improved prognosis for vascular disease associated events. While many of the atheroprotective effects of HDL are ascribed to the ability to remove cholesterol from the...
- How to stabilize unstable plaque. Hirschberg, Raimund // Cardiovascular Research;Jul2011, Vol. 91 Issue 1, p3
No abstract available.
- HDL Stimulates apoM Secretion. Ahnstr�m, Josefin; Axler, Olof; Dahlb�ck, Bj�rn // Protein & Peptide Letters;Oct2010, Vol. 17 Issue 10, p1285
No abstract available.
- Anti-Inflammatory Effects of Adiponectin on Leukocyte-Endothelium Interactions In Vivo Are Mediated by Enhanced Nitric Oxide Bio-availability and Suppression of Endothelial Cell Adhesion Molecule Expression. Ouedraogo, Raogo; Berzins, Brett; Wu, Xiangdong; Mahadev, Kalyankar; Chan, Lawrence; Henderson, Kimberly; Goldstein, Barry J.; Scalia, Rosario // Diabetes;Jun2007 Supplement 1, Vol. 56, pA190
Adiponectin is an abundant circulating protein secreted from adipocytes with vascular protective effects. To gain insight into the early effects of adiponectin on endothelial cell function in vivo, we studied the microcirculation of adiponectin deficient (AdKO) mice by intravital microscpy...
- Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE−/− mice. Douglas, Gillian; Bendall, Jennifer K.; Crabtree, Mark J.; Tatham, Amy L.; Carter, Emma E.; Hale, Ashley B.; Channon, Keith M. // Cardiovascular Research;Apr2012, Vol. 94 Issue 1, p20
Aims Vascular disease states are associated with endothelial dysfunction and increased production of reactive oxygen species derived from NADPH oxidases. However, it remains unclear whether a primary increase in superoxide production specifically in the endothelium alters the initiation or...
- ApoA-I Mimetic Peptides as Anti-Inflammatory Agents. Navab, M.; Anantharamaiah, G. M.; Reddy, S. T.; Fogelman, A. M. // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Aug2005, Vol. 5 Issue 4, p335
Apolipoprotein A-I (apoA-I) is the major protein in high density lipoprotein (HDL) and a major component of the reverse cholesterol transport pathway. ApoA-I also has been shown to have multiple anti-inflammatory properties including the ability to remove pro-inflammatory lipids, reduce monocyte...
- Reverse D4F, an Apolipoprotein-AI Mimetic Peptide, Inhibits Atherosclerosis in ApoE-null Mice. Qin, Shucun; Kamanna, Vaijinath S.; Lai, Jack H.; Liu, Tianjiao; Ganji, Shobha H.; Zhang, Linhua; Bachovchin, William W.; Kashyap, Moti L. // Journal of Cardiovascular Pharmacology & Therapeutics;Sep2012, Vol. 17 Issue 3, p334
Objective: Synthetic class A amphipathic helical peptide analogs of polipoprotein-AI (apoAI; with varied phenylalanine residues) are emerging therapeutic approaches under investigation for atherosclerosis. Utilizing retroinverso sequencing, we designed reverse-D4F (Rev-D4F) peptide with 18...
- Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles. Nakayama, Tomoko; Butler, James S; Sehgal, Alfica; Severgnini, Mariano; Racie, Tim; Sharman, Jennifer; Ding, Feng; Morskaya, Svetlana Shulga; Brodsky, Joshua; Tchangov, Lubomir; Kosovrasti, Verbena; Meys, Mike; Nechev, Lubomir; Wang, Gang; Peng, Chang Geng; Fang, Yupang; Maier, Martin; Rajeev, Kallanthottathil G; Li, Robert; Hettinger, Julia // Molecular Therapy;Aug2012, Vol. 20 Issue 8, p1582
Therapeutics based on RNA interference (RNAi) have emerged as a potential new class of drugs for treating human disease by silencing the target messenger RNA (mRNA), thereby reducing levels of the corresponding pathogenic protein. The major challenge for RNAi therapeutics is the development of...
- Recent Advances on the Antiatherogenic Effects of HDL-Derived Proteins and Mimetic Peptides. Petraki, Maria P.; Mantani, Polyxeni T.; Tselepis, Alexandros D. // Current Pharmaceutical Design;9/21/2009, Vol. 15 Issue 27, p3146
The plasma levels of high-density lipoprotein (HDL) cholesterol are inversely correlated with the risk of atherosclerosis and cardiovascular disease (CVD) in humans. One of the major mechanisms whereby HDL particles protect against atherosclerosis is that of reverse cholesterol transport from...
